Stay updated on Pembrolizumab Combo in Metastatic Melanoma: Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Metastatic Melanoma: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Metastatic Melanoma: Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.3 to v3.6.4, indicating a small update to the page's backend or content; no study details appear to be altered.
    Difference
    0.1%
    Check dated 2026-07-25T13:26:34.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The revision tag on the page has been updated to v3.6.3, indicating a newer build of the entry. This change is limited to metadata; the study information remains unchanged.
    Difference
    0.1%
    Check dated 2026-07-03T23:50:10.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    An updated revision tag from v3.6.0 to v3.6.2 appears on the page, indicating a newer version of the Study Details page. The change does not modify the study content or visible details.
    Difference
    0.1%
    Check dated 2026-06-27T00:20:37.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The study record now lists the investigator Wilson Miller and Jewish General Hospital as collaborators and adds new navigation elements and section labels (How to Read a Study Record, Common Questions, How to Join a Study) along with an updated Intervention/Treatment heading. The page revision has been updated to v3.6.0, and previously shown items such as 'Last known status was:' and 'Verified' were removed along with the older 'Intervention / Treatment' label and revision tag.
    Difference
    2%
    Check dated 2026-06-12T13:41:20.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    Revision: v3.5.5 replaces the previous Revision: v3.5.4. This reflects a page version update without altering the study details or user workflow.
    Difference
    0.1%
    Check dated 2026-06-05T09:52:13.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.3 to v3.5.4, indicating a software/backend update. No visible study details or eligibility criteria appear to be changed.
    Difference
    0.1%
    Check dated 2026-05-14T23:15:26.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Metastatic Melanoma: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Metastatic Melanoma: Clinical Trial page.